Neuraltus Pharmaceuticals, Inc.;The Regents of the University of California
发明人:
Michael S. McGrath,Arasteh Ari Azhir
申请号：
US14271054
公开号：
US09579346B2
申请日:
2014.05.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.
